Product Images Oxcarbazepine

This is a figure labeled as "Figure 1" which shows Kaplan-Meier estimates of exit rate by treatment group. There are two treatment groups: oxcarbazepine and placebo. There are two axes in the figure, the horizontal axis shows the number of days (from Day 2 to Day 11) and the vertical axis shows the exit rate. There is a logarithmic rank test performed with a p-value of 0.0001, which suggests that the two groups have different exit rates. The output shows the exit rate for each group at each day.*

The text describes a figure showing Kaplan-Meier Estimates of First Seizure Event Rate by Treatment Group. It includes a log-rank test p-value of 0.046. The figure displays the seizure rate by treatment group, showing the days from a first dose to a first seizure, with the treatment group indicated as Oxcarbazepine and the placebo.*

The figure 3 shows the results of the Kaplan-Meier estimates of exit rate by treatment group. The graph displays the exit rate on the y-axis, and the time to exit in days on the x-axis. The treatment groups "HIGH" and "LOW" are shown in the graph, and the log-rank test resulted in a p-value of 0.0001. There is no other text available to provide additional information.*

This is a description of a figure showing Kaplan-Meier estimates of the exit rate by treatment group, with time to exit in days shown on the x-axis and exit rate on the y-axis. The log-rank test with a p-value of 0.0001 is also mentioned. The text "cecih", "o", "LN RN ) AR LA RRARY RAAA LARANLARN RARRS A LARRR AR" cannot be understood and is not available for description.*

Each film-coated tablet contains 150 mg oxcarbazepine. Manufactured by Sun Pharmaceutical Industries Limited in Gujara, India. Usual Dosage: See package insert. Dispense in tight container (USP). Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP 150 mg. Controlled Room Temperature]. Keep this and all drugs out of the reach of children. Medication Guide available at https://www.sunpharma.com/usa/products. Distributed by Sun Pharmaceutical Industies, Inc. 30 Tablets.*

This is a description of a medication called Oxcarbazepine, manufactured by Sun Pharmaceutical Industries Limited in India. The recommended dosage can be found in the package insert. The tablet has a film coating, contains 300mg of the medication, and should be stored in a tight container at room temperature. A medication guide for patients is also available. This medication is distributed by Sun Pharmaceutical Industries, Inc. in Cranbury, NJ.*

Each tablet contains 600 mg of oxcarbazepine, an anticonvulsant medication used to treat seizures. It is manufactured by Sun Pharmaceutical Industries Ltd. in Gujarat, India and dispensed in a tightly sealed container. The recommended dosage is indicated in the package insert. The medication guide can be found at their website. It is important to keep this drug out of children's reach. This medicine is distributed by Sun Pharmaceutical Industries, Inc. in Cranbury, NJ, USA.*